The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from the completed dose-finding part of phase 2 study of the innate cell engager acimtamig (AFM13) in combination with AlloNK (AB-101) in relapsed or refractory classical Hodgkin lymphoma (LuminICE-203).
 
Joseph Maakaron
Research Funding - Affimed Therapeutics (Inst); Atara Biotherapeutics (Inst); Crispr Therapeutics (Inst); Fate Therapeutics (Inst); Imugene (Inst); Sanofi (Inst); Scripps Research (Inst); Vor Biopharma (Inst)
 
Tatyana Feldman
Stock and Other Ownership Interests - Genomic Testing Cooperative; OM Pharmaceutical Industries
Honoraria - ADC Therapeutics; AstraZeneca; Bristol Myers Squibb; Epizyme; Genmab; Pharmacyclics; SeaGen; Takeda
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bristol-Meyers Squibb; Epizyme; Genmab; Pharmacyclics; Seagen
Speakers' Bureau - Genmab; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); Alexion Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Daiichi (Inst); Genmab; Kymera (Inst); Merck (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Tessa Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Todd Fehniger
Consulting or Advisory Role - Affimed Therapeutics; AI proteins; WUGEN, Inc.
Research Funding - Affimed Therapeutics; HCW Biologics; Miltenyi Biotec; WUGEN, Inc.
Other Relationship - Indapta Therapeutics; Orca Bio; WUGEN, Inc.
 
Gunjan Shah
Consulting or Advisory Role - Arcellx
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene (Inst); GPCR Therapeutics (Inst); Janssen (Inst); Recordati (Inst)
 
Amitkumar Mehta
Stock and Other Ownership Interests - WITTY HEALTH
Honoraria - Gilead Sciences; Incyte
Consulting or Advisory Role - AstraZeneca; BeiGene; Gilead Sciences; Incyte; Incyte; Kyowa Kirin International; Novartis; Pharmacyclics; Roche/Genentech; Seagen; TG Therapeutics
Speakers' Bureau - ADC Therapeutics; BeiGene; BMS; Gilead Sciences; Incyte; Kyowa Kirin International; Seagen
Research Funding - ADC Therapeutics (Inst); ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Artiva (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Gilead Sciences (Inst); incyte (Inst); Innate Pharma (Inst); Juno Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Pharmacyclics/Janssen (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
 
Dipenkumar Modi
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; AstraZeneca (I); Daiichi Sankyo/Lilly (I); Genentech (I); Genmab; Seagen
Speakers' Bureau - BeiGene
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genmab (Inst); Karyopharm Therapeutics (Inst)
 
Matthew Mei
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Novartis; SeaGen; Synthekine
Speakers' Bureau - Incyte; SeaGen
Research Funding - BeiGene; Bristol-Myers Squibb; Genentech; Incyte
 
Craig Sauter
Consulting or Advisory Role - Caribou Biosciences; Celgene/Bristol-Myers Squibb; Crispr Therapeutics; CSL Behring; Gamida Cell; GlaxoSmithKline; Ipsen; Karyopharm Therapeutics; Kite, a Gilead Company; MorphoSys; Nkarta; Ono Pharmaceutical; Syncopation Life Sciences
Research Funding - Actinium Pharmaceuticals; Affimed Therapeutics; Bristol-Myers Squibb; Cargo Therapeutics; Celgene/Bristol-Myers Squibb; Genzyme; Juno Therapeutics; Nkarta; Precision Biosciences
 
Rashmi Khanal
No Relationships to Disclose
 
Stefan Barta
Honoraria - Acrotech Biopharma; Affimed Therapeutics; Daiichi Sankyo/Lilly; Janssen Oncology; Kyowa Kirin International
Consulting or Advisory Role - Acrotech Biopharma; Citius Pharmaceuticals; Ono Pharmaceutical; Secura Bio
Research Funding - Affimed Therapeutics (Inst); Bioinvent (Inst); Kymera (Inst); Ono Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Citius Pharmaceuticals; Daiichi Sankyo/Astra Zeneca; Genmab; Kyowa Kirin International; Seagen
 
Joseph Maly
No Relationships to Disclose
 
Michael Emig
Employment - Affimed Therapeutics; Lilly; Merck KGaA
Stock and Other Ownership Interests - Affimed Therapeutics
 
Lydia Wunderle
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Andre Overesch
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Kerstin Pietzko
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Alexandra Vasile
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Jennifer Rubel
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Thorsten Graef
Employment - Artiva
Stock and Other Ownership Interests - Artiva
 
Heather Raymon
Employment - Artiva
Stock and Other Ownership Interests - Artiva
 
Alison Moskowitz
Honoraria - Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Kyowa Kirin International; Merck; Pfizer; Takeda
Research Funding - ADC Therapeutics (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Secura Bio (Inst)